History of transfusion | History of liver disease | |||||
---|---|---|---|---|---|---|
n | Adjusted HR (95% CI) | P value | n | Adjusted HR (95% CI) | P value | |
Cancer (all) | ||||||
All | 71 | 1.75 (1.32–2.33) | 0.0001 | 25 | 1.26 (0.83–1.91) | 0.27 |
Men | 37 | 1.47 (1.00–2.18) | 0.0522 | 17 | 1.26 (0.76–2.09) | 0.38 |
Women | 34 | 2.18 (1.39–3.43) | 0.0007 | 8 | 1.39 (0.67–2.84) | 0.37 |
Cancer (nonliver) | ||||||
All | 64 | 1.68 (1.25–2.26) | 0.0007 | 19 | 1.00 (0.62–1.61) | 0.99 |
Men | 32 | 1.33 (0.87–2.02) | 0.18 | 13 | 1.01 (0.56–1.81) | 0.98 |
Women | 32 | 2.20 (1.38–3.51) | 0.0009 | 6 | 1.08 (0.47–2.45) | 0.86 |
Cancer (specific site) | ||||||
Lung | ||||||
All | 12 | 1.54 (0.78–3.06) | 0.22 | 4 | 1.06 (0.39–2.91) | 0.91 |
Men | 7 | 1.12 (0.46–2.75) | 0.8 | 3 | 1.09 (0.34–3.50) | 0.88 |
Women | 5 | 2.87 (0.90–9.14) | 0.07 | 1 | 1.31 (0.17–10.18) | 0.79 |
Stomach | ||||||
All | 13 | 1.99 (1.01–3.91) | 0.0462 | 4 | 1.17 (0.42–3.23) | 0.76 |
Men | 7 | 1.35 (0.55–3.34) | 0.51 | 3 | 0.78 (0.19–3.22) | 0.73 |
Women | 6 | 3.24 (0.91–11.52) | 0.0698 | 1 | 2.32 (0.53–10.11) | 0.26 |
Colorectum | ||||||
All | 6 | 1.27 (0.46–3.46) | 0.65 | 1 | 0.68 (0.09–5.02) | 0.71 |
Men | 1 | n/a | n/a | 1 | 2.40 (0.31–18.60) | 0.4 |
Women | 5 | 1.25 (0.34–4.59) | 0.7334 | 0 | n/a | n/a |
Liver | ||||||
All | 7 | 3.07 (1.14–8.31) | 0.0269 | 6 | 6.57 (2.51–17.23) | 0.0001 |
Men | 5 | 3.94 (1.19–13.08) | 0.025 | 4 | 5.45 (1.65–17.93) | 0.0053 |
Women | 2 | 2.15 (0.35–11.89) | 0.4259 | 2 | 9.04 (1.80–45.40) | 0.0075 |
Pancreas | ||||||
All | 7 | 3.34 (1.28–8.72) | 0.014 | 0 | n/a | n/a |
Men | 4 | 4.10 (1.12–14.98) | 0.0328 | 0 | n/a | n/a |
Women | 3 | 2.57 (0.63–10.60) | 0.1905 | 0 | n/a | n/a |
Other | ||||||
All | 26 | 1.47 (0.89–2.42) | 0.13 | 9 | 1.26 (0.61–2.59) | 0.53 |
Men | 13 | 1.32 (0.67–2.57) | 0.42 | 6 | 1.12 (0.45–2.77) | 0.81 |
Women | 13 | 1.70 (0.80–3.61) | 0.16 | 3 | 1.58 (0.49–5.13) | 0.45 |